Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.
REGISTERED
on 13 Sep 2023
RETRIG
SFJ PHARMA X INC.
2165742 · 28 Dec 2021
005
Class 005
Pharmaceutical Products
Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.
Pharmaceutical preparation, namely, a recombinant, human monoclonal an...
